BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Wu J, Yuan Y, Lu Y, Luo M, Lin L, Ma S. Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma. Front Cell Dev Biol 2021;9:673838. [PMID: 34124058 DOI: 10.3389/fcell.2021.673838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hurdogan O, De Logu F, Galli F, Tuncer S, Ugolini F, Simi S, Portelli F, Nassini R, Massi D, Buyukbabani N. Digital Quantification of Intratumoral CD8+ T-Cells Predicts Relapse and Unfavorable Outcome in Uveal Melanoma. Cancers (Basel) 2022;14. [PMID: 36497441 DOI: 10.3390/cancers14235959] [Reference Citation Analysis]
2 Dong H, Xie C, Yao Z, Zhao R, Lin Y, Luo Y, Chen S, Qin Y, Chen Y, Zhang H. PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer. Front Immunol 2022;13:947841. [DOI: 10.3389/fimmu.2022.947841] [Reference Citation Analysis]
3 Yu S, Li X, Ma M, Yang R, Zhang J, Wu S. The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer. Cancers (Basel) 2022;14. [PMID: 35626004 DOI: 10.3390/cancers14102399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]